Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Habbick

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 15, 1991
Pregnancy outcome among native Indians in SaskatchewanL Edouard, D Gillis, B Habbick
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 15, 1995
Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in SaskatchewanB Habbick, M J Baker, M McNutt, et al.
Lancet (London, England)|June 27, 1998
Questions on breast-implants studyP Clark, E Garbe, B Habbick, et al.
The Medical Journal of Australia|October 19, 1992
Fenoterol and death from asthmaW O Spitzer, P Ernst, S Suissa, et al.
The American Review of Respiratory Disease|July 1, 1993
Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity?P Ernst, B Habbick, S Suissa, et al.
Chest|December 1, 1991
Clinical complexity and epidemiologic uncertainty in case-control research. Fenoterol and asthma managementR I Horwitz, W Spitzer, S Buist, et al.
JAMA|December 23, 1992
Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid useP Ernst, W O Spitzer, S Suissa, et al.
American Journal of Respiratory and Critical Care Medicine|March 1, 1994
A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonistsS Suissa, P Ernst, J F Boivin, et al.
The New England Journal of Medicine|February 20, 1992
The use of beta-agonists and the risk of death and near death from asthmaW O Spitzer, S Suissa, P Ernst, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 15, 1991
Pregnancy outcome among native Indians in SaskatchewanL Edouard, D Gillis, B Habbick
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 15, 1995
Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in SaskatchewanB Habbick, M J Baker, M McNutt, et al.
Lancet (London, England)|June 27, 1998
Questions on breast-implants studyP Clark, E Garbe, B Habbick, et al.
The Medical Journal of Australia|October 19, 1992
Fenoterol and death from asthmaW O Spitzer, P Ernst, S Suissa, et al.
The American Review of Respiratory Disease|July 1, 1993
Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity?P Ernst, B Habbick, S Suissa, et al.
Chest|December 1, 1991
Clinical complexity and epidemiologic uncertainty in case-control research. Fenoterol and asthma managementR I Horwitz, W Spitzer, S Buist, et al.
JAMA|December 23, 1992
Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid useP Ernst, W O Spitzer, S Suissa, et al.
American Journal of Respiratory and Critical Care Medicine|March 1, 1994
A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonistsS Suissa, P Ernst, J F Boivin, et al.
The New England Journal of Medicine|February 20, 1992
The use of beta-agonists and the risk of death and near death from asthmaW O Spitzer, S Suissa, P Ernst, et al.
Pageof 1